Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-15,300
Closed -$4.72M 4916
2025
Q3
$4.72M Buy
+15,300
New +$4.79M ﹤0.01% 2265
2024
Q2
Sell
-28,900
Closed -$4.95M 4777
2024
Q1
$4.95M Buy
28,900
+27,600
+2,123% +$5.15M ﹤0.01% 1895
2023
Q4
$282K Sell
1,300
-2,600
-67% -$446K ﹤0.01% 3768
2023
Q3
$622K Buy
+3,900
New +$873K ﹤0.01% 3338
2022
Q4
Sell
-10,000
Closed -$2.29M 5062
2022
Q3
$2.29M Hold
10,000
﹤0.01% 2871
2022
Q2
$2.18M Buy
+10,000
New +$2.27M ﹤0.01% 2991
2021
Q4
Sell
-10,000
Closed -$2.84M 5647
2021
Q3
$2.84M Hold
10,000
﹤0.01% 2676
2021
Q2
$2.75M Buy
+10,000
New +$2.72M ﹤0.01% 2614
2020
Q4
Sell
-27,300
Closed -$6.46M 4116
2020
Q3
$6.46M Hold
27,300
0.01% 1522
2020
Q2
$5.3M Sell
27,300
-3,900
-13% -$746K 0.01% 1632
2020
Q1
$5.17M Buy
31,200
+12,800
+70% +$2.34M 0.01% 1439
2019
Q4
$3.15M Buy
+18,400
New +$3.07M ﹤0.01% 2111
2018
Q4
Sell
-17,000
Closed -$1.8M 3936
2018
Q3
$1.8M Hold
17,000
﹤0.01% 2269
2018
Q2
$1.46M Buy
+17,000
New +$1.52M ﹤0.01% 2448
2014
Q2
Sell
-5,000
Closed -$237K 4456
2014
Q1
$237K Buy
+5,000
New +$221K ﹤0.01% 4021

Other funds holding PODD

David Shaw's PODD Position: Q2 2026 in Review

David Shaw increased its Insulet (PODD) stake by 219% in Q2 2026, buying an estimated $48.8M and bringing the position to 426,520 shares worth $64.9M. The position accounts for 0.03% of the portfolio, ranked #633.

David Shaw first reported a position in PODD in Q2 2013 and has held it in 46 quarters since. The position peaked at $151M in Q3 2018. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

  • David Shaw held 426,520 shares of Insulet worth $64.9M as of Q2 2026.
  • David Shaw bought 292,923 Insulet shares in Q2 2026, an estimated $48.8M.
  • Insulet made up 0.03% of David Shaw's portfolio in Q2 2026, its #633 holding.
  • David Shaw first reported a position in Insulet in Q2 2013 and has held it in 46 quarters since.
  • David Shaw's Insulet position peaked at $151M in Q3 2018.
  • 720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.